Efficacy and safety of nemolizumab in patients with moderate to severe prurigo nodularis: The OLYMPIA 1 randomized clinical phase 3 trial - Ständer, Sonja; Yosipovitch, Gil; Legat, Franz J.; Reich, Adam; Paul, Carle; Simon, Dagmar; Naldi, Luigi; Metz, Martin; Tsianakas, Athanasios; Pink, Andrew; Fage, Simon; Micali, Giuseppe; et al. (JAMA dermatology, 2024)
Gesehen am 06.10.2025